|
1
|
Yamada T, Alpers DH, Kalloo AN, Kaplowitz
N, Owyang C and Powell DN: editor. Text of gastroenterology, 5th
ed. Oxford: Blackwell Publishing Ltd. 2009. View Article : Google Scholar
|
|
2
|
Cheung AC, Patel H, Meza-Cardona J, Cino
M, Sockalingam S and Hirschfield GM: Factors that influence
health-related quality of life in patients with primary sclerosing
cholangitis. Dig Dis Sci. 61:1692–1699. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Benito de Valle M, Rahman M, Lindkvist B,
Björnsson E, Chapman R and Kalaitzakis E: Factors that reduce
health-related quality of life in patients with primary sclerosing
cholangitis. Clin Gastroenterol Hepatol. 10:769–775.e2.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gutteling JJ, de Man RA, Busschbach JJ and
Darlington AS: Overview of research on health-related quality of
life in patients with chronic liver disease. Neth J Med.
65:227–234. 2007.PubMed/NCBI
|
|
5
|
World Health Organization. Global
hepatitis report, 2017. Geneva, Switzerland: World Health
Organization, 2017.
|
|
6
|
Chalasani N, Younossi Z, Lavine JE, Diehl
AM, Brunt EM, Cusi K, Charlton M and Sanyal AJ: The diagnosis and
management of non-alcoholic fatty liver disease: Practice Guideline
by the American Association for the Study of Liver Diseases,
American College of Gastroenterology, and the American
gastroenterological association. Hepatology. 55:2005–2023.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hoofnagle JH, Doo E, Liang TJ, Fleischer R
and Lok AS: Management of hepatitis B: Summary of a clinical
research workshop. Hepatology. 45:1056–1075. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bonacini M: Pruritus in patients with
chronic human immunodeficiency virus, hepatitis B and C virus
infections. Dig Liver Dis. 32:621–625. 2000.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Oeda S, Takahashi H, Yoshida H, Ogawa Y,
Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, et al:
Prevalence of pruritus in patients with chronic liver disease: A
multicenter study. Hepatol Res. 48:E252–E262. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cacoub P, Poynard T, Ghillani P, Charlotte
F, Olivi M, Piette JC and Opolon P: Extrahepatic manifestations of
chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.
Arthritis Rheum. 42:2204–2212. 1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Talwalkar JA, Souto E, Jorgensen RA and
Lindor KD: Natural history of pruritus in primary biliary
cirrhosis. Clin Gastroenterol Hepatol. 1:297–302. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jupiter DC: Propensity score matching:
Retrospective randomization? J Foot Ankle Surg. 56:417–420.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT,
Thomas DL, et al: Development of a simple noninvasive index to
predict significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wai CT, Greenson JK, Fontana RJ,
Kalbfleisch JD, Marrero JA, Conjeevaram HS and Lok AS: A simple
noninvasive index can predict both significant fibrosis and
cirrhosis in patients with chronic hepatitis C. Hepatology.
38:518–526. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sandrin L, Fourquet B, Hasquenoph JM, Yon
S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, et
al: Transient elastography: A new noninvasive method for assessment
of hepatic fibrosis. Ultrasound Med Biol. 29:1705–1713.
2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aitken RC: Measurement of feelings using
visual analogue scales. Proc R Soc Med. 62:989–993. 1969.PubMed/NCBI
|
|
17
|
Akuta N, Kumada H, Fujiyama S, Kawamura Y,
Sezaki H, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y,
et al: Predictors of pruritus in patients with chronic liver
disease and usefulness of nalfurafine hydrochloride. Hepatol Res.
48:45–50. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sumi R, Fukuda K, Irishio K, Hattori M,
Sawai Y, Kogita S, Igura S, Yamaguchi Y, Matsumoto Y, Nakahara M,
et al: Current status of pruritus in chronic liver diseases and
efficacy of nalfurafine hydrochloride. Kanzo. 58:486–493. 2017.(In
Japanese).
|
|
19
|
Grigorescu I and Dumitrascu DL:
Spontaneous and antiviral-induced cutaneous lesions in chronic
hepatitis B virus infection. World J Gastroenterol. 20:15860–15866.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gianotti F: Papular acrodermatitis of
childhood. An Australia antigen disease. Arch Dis Child.
48:794–799. 1973.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ishimaru Y, Ishimaru H, Toda G, Baba K and
Mayumi M: An epidemic of infantile papular acrodermatitis
(Gianotti's disease) in Japan associated with hepatitis-B surface
antigen subtype ayw. Lancet. 1:707–709. 1976. View Article : Google Scholar
|
|
22
|
Kacprzak-Bergman I and Halasa J: Frequency
of complement third component (C3) and properdin factor (BF)
phenotypes in patients with various clinical manifestations of HBV
infection. Eur J Immunogenet. 23:1–6. 1996.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kartal ED, Alpat SN, Ozgunes I and Usluer
G: Adverse effects of high-dose interferon-alpha-2a treatment for
chronic hepatitis B. Adv Ther. 24:963–971. 2007.PubMed/NCBI
|
|
24
|
Yilmaz S and Cimen KA: Pegylated
interferon alpha-2B induced lupus in a patient with chronic
hepatitis B virus infection: Case report. Clin Rheumatol.
28:1241–1243. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
García-Porrúa C, González-Gay MA,
Fernández-Lamelo F, Paz-Carreira JM, Lavilla E and González-López
MA: Simultaneous development of SLE-like syndrome and autoimmune
thyroiditis following alpha-interferon treatment. Clin Exp
Rheumatol. 16:107–108. 1998.PubMed/NCBI
|
|
26
|
Criado PR, de Oliveira Ramos R,
Vasconcellos C, Jardim Criado RF and Valente NY: Two case reports
of cutaneous adverse reactions following hepatitis B vaccine:
Lichen planus and granuloma annulare. J Eur Acad Dermatol Venereol.
18:603–606. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mérigou D, Léauté-Labrèze C, Louvet S,
Bioulac-Sage P and Taïeb A: Lichen planus in children: Role of the
campaign for hepatitis B vaccination. Ann Dermatol Venereol.
125:399–403. 1998.(In French). PubMed/NCBI
|
|
28
|
Guidotti LG and Chisari FV: Immunobiology
and pathogenesis of viral hepatitis. Annu Rev Pathol. 1:23–61.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Guidotti LG, Matzke B, Schaller H and
Chisari FV: High-level hepatitis B virus replication in transgenic
mice. J Virol. 69:6158–6169. 1995.PubMed/NCBI
|
|
30
|
Reig A, Sesé P and Parés A: Effects of
Bezafibrate on outcome and pruritus in primary biliary cholangitis
with suboptimal ursodeoxycholic acid response. Am J Gastroenterol.
113:49–55. 2018.PubMed/NCBI View Article : Google Scholar
|
